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Abstract  24 
Laparoscopic ovarian drilling (LOD) has been widely utilised as an effective treatment in anovulatory 25 
women with polycystic ovarian syndrome (PCOS). However, there has been a growing concern over a 26 
possible damaging effect of this procedure on ovarian reserve. The objective of this study was to 27 
investigate the hypothesis that LOD compromises ovarian reserve as measured by post-operative 28 
changes in circulating anti-Müllerian hormone (AMH). This meta-analysis included all cohort studies 29 
as well as randomised controlled trials investigating serum AMH concentrations and other ovarian 30 
reserve markers in PCOS women undergoing LOD. Various databases were searched including 31 
MEDLINE, EMBASE, Dynamed Plus, ScienceDirect, TRIP database, ClinicalTrials.gov and 32 
Cochrane Library from January 2000 to December 2016. Sixty studies were identified, of which seven 33 
were deemed eligible for this review. AMH data were extracted from each study and entered into 34 
RevMan software to calculate the weighted mean difference (WMD) between pre- and post-operative 35 
values. Pooled analysis of all studies (n=442) revealed a statistically significant decline in serum 36 
AMH concentration after LOD (WMD -2.13ng/ml; 95% confidence interval (CI) -2.97 to -1.30). 37 
Subgroup analysis based on duration of follow-up, AMH kit, laterality of surgery and amount of 38 
energy applied during LOD consistently showed a statistically significant fall in serum AMH 39 
concentration. In conclusion, although LOD seems to markedly reduce circulating AMH, it remains 40 
uncertain whether this reflects a real damage to ovarian reserve or normalisation of the high 41 
preoperative serum AMH levels. Further long-term studies on ovarian reserve after LOD are required 42 
to address this uncertainty. 43 
 44 
 45 
Key words: Anti-Müllerian hormone, Laparoscopic ovarian drilling, ovarian diathermy, ovarian 46 
electrocautery, ovarian reserve, polycystic ovarian syndrome 47 
  48 
Page 2 of 27
3 
 
Introduction 49 
Polycystic ovarian syndrome (PCOS) is a very common ovarian endocrinopathy with a prevalence of 50 
6-20% amongst women of reproductive age (Yildiz et al. 2012) and about 90% amongst women with 51 
anovulatory of infertility (Hull 1987). It is characterized by a varied combination of clinical 52 
(anovulation and hyperandrogenism), biochemical (excess serum luteinizing hormone and androgen 53 
concentrations) and ovarian morphological (polycystic ovaries) features.  54 
For PCOS women with anovulatory infertility, laparoscopic ovarian drilling (LOD) has been well-55 
established as a successful second line treatment for ovulation induction after failure of clomiphene 56 
citrate (Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2008, Farquhar 57 
et al.  2012).  In addition to being as effective as gonadotrophin ovarian stimulation, LOD, offers 58 
several advantages over this treatment such as avoiding ovarian hyperstimulation syndrome and 59 
multiple pregnancies, reducing costs and negating the need for complex monitoring (Bayram et al.  60 
2004, Farquhar et al. 2012). Furthermore, with LOD, a single treatment leads to repeated 61 
physiological ovulatory cycles and potentially repeated pregnancies without the need for repeated 62 
courses of medical treatment. Moreover, several follow-up studies provided evidence of long-term 63 
reproductive and endocrinological benefits of LOD (Gjønnæss 1998, Amer et al. 2002, Nahuis et al. 64 
2012). We have previously reported long-term improvement in menstrual cycles and reproductive 65 
performance in about a third of PCOS women undergoing LOD for up to nine years (Amer et al. 66 
2002). Similarly, Nahuis et al. (2012) followed PCOS women for up to 12 years after LOD reporting 67 
high pregnancy rate (61% conception of a second child) with long-term improvement of menstrual 68 
cycles in 44% of cases. 69 
Despite its proven efficacy, there has been a growing concern over the possible damaging effect of 70 
LOD on ovarian reserve. Our group and several other researchers have previously reported a 71 
significant reduction in serum anti-Müllerian hormone after LOD (Weerakiet et al. 2007, Amer et al. 72 
2009, Elmashad 2011, Farzadi et al. 2012, Syam et al. 2014, Sunj et al. 2014a,  Rezk et al. 2016, 73 
Giampaolino et al.  2016). However, given the relatively small numbers of patients included in these 74 
studies, further evidence is required to allow a firm conclusion.  75 
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Anti-Müllerian hormone (AMH) is exclusively secreted by granulosa cells of growing follicles 76 
including primary, pre-antral, small antral (4-6 mm) and to less extent larger antral follicles (7-9 mm) 77 
(Weenen et al. 2004, Anderson et al. 2010). Thus, circulating AMH is now widely accepted as a 78 
reliable marker for ovarian reserve (Coccia and Rizzello, 2008; Robertson, 2008; Andersen et al. 79 
2010). Furthermore, serum AMH concentration is generally stable with minimal inter- and intra-cycle 80 
fluctuations making it an ideal candidate for detecting small changes in ovarian reserve following 81 
LOD (Lambert-Messerlian et al. 2016). 82 
Based on the above, we have designed this systematic review and meta-analysis aiming to investigate 83 
the impact of LOD on ovarian reserve as determined mainly by serum AMH levels.    84 
Materials and Methods: 85 
This meta-analysis was carried out according to the Preferred Reporting Items for Systematic Reviews 86 
and Meta-analyses (PRISMA) guidelines (Liberati et al. 2009) and was registered in PROSPERO 87 
(CRD42016039687). 88 
Inclusion criteria  89 
This meta-analysis included all published cohort studies as well as randomized controlled trials 90 
(RCTs) that investigated changes in serum anti-Müllerian hormone (AMH) concentration in 91 
anovulatory women with PCOS undergoing LOD. 92 
Outcome measures 93 
Primary measure: 94 
This included postoperative changes in serum AMH concentration.  95 
Secondary measures: 96 
These included postoperative changes in serum follicle stimulating hormone (FSH) concentration and 97 
antral follicle count (AFC) on ultrasound scan. 98 
Search strategy 99 
A detailed electronic search was conducted using numerous databases from January 2000 to June 100 
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2016 to identify studies investigating the effect of laparoscopic ovarian drilling on circulating AMH 101 
levels and other markers of ovarian reserve. Databases included MEDLINE (31 studies), Embase (29 102 
studies), Dynamed (0), ScienceDirect (0), TRIP database (0), ClinicalTrials.gov (0) and the Cochrane 103 
Library (0). Medical Subject Headings (MeSH) terms used included: laparoscopy, polycystic ovary 104 
syndrome, ovarian drilling, ovarian diathermy, ovarian electrocautery, ovarian reserve, anti-Müllerian 105 
hormone and antral follicle count.  Search was limited to the English Language, adult Females of 106 
reproductive age. Three co-authors (AM, TE and AY) conducted the searches and then an accredited 107 
clinical librarian (CJ) independently repeated the search using the same criteria. All identified articles 108 
were retrieved, and their reference lists were manually checked for further relevant studies. Published 109 
conference abstracts, which could be identified from ScienceDirect database, were also considered for 110 
the analysis.  111 
Study selection 112 
Three investigators (AM, TE and AY) independently screened the title and abstract of all identified 113 
articles to assess relevance to our meta-analysis. In case of disagreement, the full text was retrieved 114 
and reviewed independently by a senior author (SA) for a final decision. 115 
All identified articles were evaluated according to a standardized format including study design, 116 
methods, participant characteristics, intervention, and results. Three investigators scored the studies 117 
and collected the information independently (AM, TE, AY). In case of discrepancies in scoring 118 
between the three investigators, a consensus was reached after discussion or after involvement of the 119 
senior investigator (SA).  120 
In two studies, the mean±SD of serum AMH was missing as data were presented as median and range 121 
(Amer et al. 2009, Sunj et al. 2014a). The mean±SD was also missing for AFC in two studies 122 
(Farzadi et al. 2012, Sunj et al. 2014a)
 
and for FSH in four studies (Weerakiet et al. 2007, Sunj et al. 123 
2014a, Giampaolino, et al, 2016, Rezk et al. 2016,). We obtained the mean±SD of serum AMH and 124 
FSH levels from the original data of our previous study (Amer et al. 2009). Authors of the other 125 
studies were contacted and three (Sunj et al. 2014, Giampaolino et al. 2016, Rezk et al. 2016) 126 
responded providing the missing data. 127 
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Quality of included studies and risk of bias assessment  128 
Modified Newcastle-Ottawa scale was utilised for assessing the quality and risk of bias of the 129 
included studies (Raffi et al. 2012, Mohamed et al. 2016). Each article was scored according to three 130 
categories including selection (maximum three stars), comparability (four stars), and outcomes (two 131 
stars). Selection was rated according to recruitment bias, selection of consecutive patients and power 132 
calculation. Comparability was assessed based on adjustment of analysis for four confounders 133 
including patients’ age (<40), baseline serum AMH, laterality of surgery and number of punctures 134 
according to estimated ovarian volume, type of instrument and energy used. Outcome was scored 135 
according to completeness of at least three-month follow-up after surgery. In the current analysis, we 136 
have given more weight to comparability factors and used the cut-off level of six stars with a 137 
minimum of three stars in the comparability category (Raffi et al. 2012, Mohamed et al. 2016). Table 138 
1 shows the results of quality scores of the studies included in this analysis. 139 
Data extraction and analysis  140 
Pre- and post-operative mean±SD serum AMH (ng/ml) and FSH (mIU/ml) concentrations and AFC 141 
were extracted from the individual articles and entered into RevMan software (Review Manager, 142 
version 5.1, The Cochrane Collaboration, 2011; The Nordic Cochrane Centre, Copenhagen, Denmark) 143 
for meta-analysis. The weighted mean difference (WMD) between pre- and post-operative values was 144 
calculated. Statistical heterogeneity between studies was assessed by I-squared (I2) statistics and 145 
values of ≥50% were indicative of high heterogeneity (Higgins et al. 2003). When heterogeneity was 146 
significant, a random-effect model was used for meta-analysis. Fixed effect meta-analysis was used 147 
when there was no significant heterogeneity.  148 
Overall analysis of data from all studies was first performed, irrespective of duration of the follow up, 149 
laterality of surgery and type of AMH assay kit used. In studies with multiple measurements at 150 
different post-operative follow up points, the latest AMH measurement was used for the overall 151 
analysis. In order to account for confounding factors, subgroup analyses were performed based on 152 
duration of follow-up, AMH kits used, laterality (bilateral and unilateral) of LOD and amount of 153 
energy applied during LOD. No sensitivity analysis was performed as all the studies scored high on 154 
the Modified Newcastle-Ottawa scale indicating low risk of bias (Table 1). 155 
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Results 156 
The electronic database search identified 60 studies. All articles were screened and relevant articles 157 
were fully reviewed for eligibility for the study objectives and inclusion criteria. As a result, seven 158 
articles were deemed eligible for this meta-analysis (Fig.1). 159 
Excluded studies  160 
Of the 60 identified articles, fifty-one did not use the anti-Müllerian hormone as a marker of ovarian 161 
reserve and were therefore excluded from this meta-analysis. Two further studies were excluded, one 162 
due to lack of preoperative serum AMH levels (postoperative AMH levels were compared with a 163 
control group) (Weerakiet et al. 2007), and the other one (Sunj et al. 2014b) due to duplication of 164 
another study (Sunj et al. 2014a), which is included in the meta-analysis.  165 
Included studies 166 
Details of the seven studies are shown in table 2. 167 
Study design 168 
This systematic review included five cohort studies (Amer et al. 2009, Elmashad 2011, Farzadi et 169 
al. 2012, Seyam et al. 2014, Sunj et al. 2014a) and two RCTs (Giampaolino et al. 2016, Rezk et 170 
al. 2016). The RCT by Rezk et al. (2016) compared unilateral versus bilateral LOD. The two arms of 171 
this RCT were combined and used as a cohort study in the overall analysis, and then each arm was 172 
included separately in subgroup analysis. The other RCT compared laparoscopic versus transvaginal 173 
hydro-laparoscopic ovarian drilling (TH-LOD) (Giampaolino et al. 2016). Only the LOD group of this 174 
RCT was included as a cohort study in the current meta-analysis (Giampaolino et al. 2016).    175 
Participants 176 
All studies used appropriate selection criteria and all participants underwent the same surgical 177 
techniques of LOD. Inclusion and exclusion criteria were appropriately reported in all studies. All 178 
patients were accounted for in all studies.  179 
PCOS diagnosis 180 
All seven studies included in this meta-analysis utilised Rotterdam criteria for the diagnosis of PCOS 181 
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(Amer et al.  2009, Elmashad 2011, Farzadi et al. 2012, Seyam et al. 2014, Sunj et al. 2014a, Rezk et 182 
al. 2016, Giampaolino et al. 2016). 183 
Laparoscopic ovarian drilling  184 
Laparoscopic ovarian drilling (LOD) was performed using monopolar diathermy needle in six studies 185 
(Amer et al.  2009, Elmashad 2011, Seyam et al. 2014, Sunj et al. 2014a, Rezk et al. 2016, 186 
Giampaolino et al. 2016).  The remaining study used monopolar hook diathermy for LOD (Farzadi et 187 
al, 2012). One study randomised patients to undergo either LOD or TH-LOD, but only the LOD arm 188 
was included in the meta-analysis (Giampaolino et al, 2016).  189 
With regards to the number of punctures and amount of energy delivered to the ovary during LOD, 190 
two studies reported four punctures per ovary at a power setting of 30W applied for 5 seconds per 191 
puncture i.e. 450 joules (J) per ovary (Amer et al. 2009, Elmashad 2011). In the two studies 192 
comparing bilateral versus unilateral LOD, the authors applied 600 J per ovary (5 punctures x 4s x 193 
30W) in the bilateral group and 60 J per 1cm3 of ovarian volume in the unilateral group (delivered as 194 
30W for 4s per puncture), which is equivalent to 627 J applied to a 10cm
3
 ovary (Sunj et al. 2014a, 195 
Rezk et al. 2016). Seyam and co-workers reported 4-6 punctures per ovary at a power of 30 W for 4–5 196 
seconds per puncture i.e. 480 – 900 J per ovary (Seyam et al. 2014). Giampaolino et al. (2016) 197 
applied 3-6 punctures per ovary using 40 W for 4–5 seconds per puncture i.e. 480–1200 J per ovary. 198 
One study reported six to seven punctures per ovary, but no details were provided regarding the power 199 
setting or the duration of each puncture (Farzadi et al. 2012).  200 
Concerning laterality, five studies reported that LOD was carried out bilaterally (Amer et al. 2009, 201 
Elmashad 2011, Farzadi et al. 2012, Seyam et al. 2014, Giampaolino et al. 2016). The remaining two 202 
studies compared unilateral versus bilateral LOD (Sunj et al. 2014a, Rezk et al. 2016). 203 
Length of follow up after LOD 204 
Six studies completed six-month follow-up after LOD, (Amer et al. 2009, Farzadi et al. 2012, 205 
Seyam et al. 2014, Sunj et al. 2014a, Rezk et al. 2016, Giampaolino et al. 2016) whilst the 206 
remaining study followed participants for three months (Elmashad 2011). Four studies carried out 207 
multiple measurements within one month (Amer et al. 2009, Farzadi et al. 2012, Seyam et al. 208 
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2014, Sunj et al. 2014a) and three months (Table 2) (Amer et al. 2009, Farzadi et al. 2012, 209 
Seyam et al. 2014, Rezk et al. 2016). 210 
AMH kits 211 
Four AMH kits were used in different studies (Table 2). Immunotech (IOT) AMH enzyme 212 
immunoassay kit (Immunotech, Beckman Coulter, Marseille, France) was used in Four studies (Amer 213 
et al. 2009, Elmashad 2011, Rezk et al. 2016; Seyam et al. 2014). The intra- and inter-assay 214 
coefficients of variation for this AMH assay are below 12.3% and 14.2%, respectively, with a 215 
detection limit of 0.14ng/ml. The modified AMH Gen II enzyme linked immunosorbent assay 216 
(ELISA) (Beckman Coulter, Chaska, MN, USA) was used by one study (Sunj et al. 2014a). The 217 
intra and inter-assay coefficients of variation for this AMH kit are both below 10%, with a detection 218 
limit of 0.08ng/ml. Farzadi et al. (2012) used AMH enzyme immunoassay (EIA) kit (ELAab & 219 
USCNLIFE, Wuhan ELAab Science Co.Ltd). The lowest detection limit of this assay is 0.053ng/ml 220 
according to instructions provided in the analysis kit.
11
 The last study used DSL active AMH ELISA 221 
kit (Diagnostic Systems Laboratories, Webster TX). The intra-assay and interassay coefficients of 222 
variation for this kit were 4.6% and 8.0%, respectively, with a detection limit of 0.017ng/ml 223 
(Giampaolino et al. 2016). 224 
Antral follicle count 225 
Four studies reported the AFC as an outcome measure of ovarian reserve (Elmashad 2011, Farzadi et 226 
al. 2012, Rezk et al. 2016, Seyam et al. 2014). The authors of another study provided the AFC 227 
data, which were missing from the published article, in response to our communication (Sunj 228 
et al. 2014a). Elmashad (2011) defined AFC as the number of follicles measuring 2–9 mm in 229 
diameter. Seyam and co-workers (2014) defined AFC as the count of all follicles measuring 230 
2-10 mm in diameter. The remaining three studies did not define the size of the follicles used 231 
for the AFC, but reported using the Rotterdam definition of polycystic ovaries (>12 follicles 232 
measuring 2-9 mm) (Farzadi et al. 2012, Rezk et al. 2016, Sunj et al. 2014a). 233 
Potential source of bias  234 
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In all seven studies, selection methods were clearly described and recruitment followed a consecutive 235 
fashion. This made it possible to assess selection bias in all studies. 236 
Pooled results  237 
Overall results  238 
Table 3 shows mean±SD serum AMH concentrations before and after LOD in all seven 239 
studies. Pooled analysis of all seven studies including 442 participants revealed a statistically 240 
significant decline of serum AMH concentration after LOD (WMD -2.13ng/ml; 95% 241 
confidence interval (CI) -2.97 to -1.30). Heterogeneity between studies was high (I
2
 = 87 %) 242 
(Fig. 2) (Amer et al. 2009, Elmashad 2011, Farzadi et al. 2012, Seyam et al. 2014, Sunj et al. 2014a, 243 
Giampaolino et al. 2016, Rezk et al. 2016). 244 
Subgroup analysis 245 
Studies using different AMH assays 246 
Pooled results of four studies (n=197) using IOT AMH kit showing a statistically significant drop in 247 
serum AMH concentration (WMD -2.80; 95% CI -3.22 to -2.38; I
2
=0%) with low heterogeneity 248 
between studies (Amer et al. 2009, Elmashad 2011, Seyam et al. 2014, Rezk et al. 2016). Each of the 249 
other three AMH assays (Modified Gen II, DSL and Abbott Diagnostic kits) was used by one study 250 
and meta-analysis was therefore not possible (Farzadi et al. 2012, Sunj et al. 2014a, Giampaolino et 251 
al. 2016). 252 
Studies with different length of follow-up 253 
Analysis of four studies including 195 patients revealed a statistically significant decline in serum 254 
AMH concentration one month after LOD (WMD -2.11; 95% CI -2.62 to -1.59; I2= 17%) (Amer et al. 255 
2009, Farzadi et al. 2012, Seyam et al. 2014, Sunj et al. 2014a). Similarly, analysis of data from five 256 
studies (n=277) with a three-month follow-up showed a statistically significant fall in serum AMH 257 
concentration after surgery (WMD, -2.74; 95% CI -3.16 to -2.33; I2=0%) (Amer et al. 2009, Elmashad 258 
2011, Farzadi et al. 2012, Seyam et al. 2014, Rezk et al. 2016). Analysis of six studies (n=419) 259 
showed a statistically significant decline in serum AMH concentration six months after LOD (WMD, 260 
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-2.03; 95% CI -2.90 to –1.16; I2= 88%) (Amer et al. 2009, Farzadi et al. 2012, Seyam et al. 2014, 261 
Sunj et al. 2014a, Giampaolino et al. 2016, Rezk et al. 2016). 262 
Laterality of LOD 263 
Bilateral LOD was performed in seven studies including 341 patients (Amer et al. 2009, Elmashad 264 
2011, Farzadi et al. 2012, Seyam et al. 2014, Sunj et al. 2014a, Giampaolino et al. 2016, Rezk et al. 265 
2016). Pooled analysis of these studies revealed a statistically significant drop in circulating serum 266 
AMH (WMD -2.31; 95% CI -3.29 to -1.33; I2= 87%). Analysis of two studies (n=101) measuring 267 
serum AMH changes after unilateral LOD showed a statistically significant decline in postoperative 268 
serum AMH concentration (WMD -1.59; 95% CI -2.69 to -0.49; I2= 69%) (Sunj et al. 2014a, Rezk et 269 
al. 2016). 270 
Sub-analysis According to energy delivered to ovaries during LOD 271 
Four studies including 253 patients used up to 600 J in ovarian drilling. Pooled analysis of these 272 
studies revealed a statistically significant drop in postoperative serum AMH levels (WMD -2.45; 95% 273 
CI -3.41 to -1.48; I
2
= 72%) (Amer et al. 2009, Elmashad 2011, Sunj et al. 2014a, Rezk et al. 2016). 274 
Two studies with 159 patients were identified using up to 900-1200 J in ovarian drilling. Pooled 275 
analysis of the results showed a statistically significant decline in postoperative serum AMH 276 
concentrations (WMD -1.93; 95% CI -3.72 to -0.14; I
2
= 94%) (Seyam et al. 2014, Giampaolino et 277 
al,.2016). 278 
Secondary outcomes: 279 
Table 4 shows serum FSH concentrations before and after LOD in six studies (n=412). Pooled 280 
analysis of these studies revealed no change in circulating FSH (WMD 0.03; 95% CI -0.46 to 0.52; 281 
I2= 90%) (Amer et al. 2009, Elmashad 2011, Seyam et al. 2014, Sunj et al. 2014a, Giampaolino et al. 282 
2016, Rezk et al. 2016). 283 
Five studies measured post-LOD changes in AFC, of which one was excluded due to lacking 284 
postoperative mean±SD AFC (Farzadi et al. 2012). Table 5 shows AFC results of the included four 285 
studies. Pooled data of these studies showed no significant change in AFC (WMD -3.46; 95% CI -286 
10.73 to 3.81; I2= 99%) (Elmashad 2011, Seyam et al. 2014, Sunj et al. 2014a, Rezk et al. 2016). 287 
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Further analysis was carried out to AFC follow-up within three and six months. Follow-up within 288 
three months were carried out with four studies including 264 patients. Pooled analysis of the results 289 
showed no significant changes in AFC after surgery (WMD -5.51; 95% CI -11.20 to 0.19; I
2
= 99%) 290 
(Elmashad 2011, Seyam et al. 2014, Sunj et al. 2014a, Rezk et al. 2016). Three studies with 241 291 
patients were identified performing follow-up assessment of AFC at six months. Pooled analysis of 292 
these studies revealed no significant change to AFC postoperative (WMD 0.04; 95% CI -5.52 to 5.59; 293 
I2= 98%) (Seyam et al. 2014, Sunj et al. 2014a, Rezk et al. 2016). 294 
Discussion 295 
This is the first systematic review and meta-analysis to investigate the impact of LOD on ovarian 296 
reserve as determined by changes in postoperative serum AMH concentration. The overall analysis 297 
revealed a marked decline of 2.13 ng/ml, which represents 43% of the cut-off level of serum AMH 298 
concentration (4.9ng/ml) in women with PCOS (Dewailly et al. 2011). This decline in circulating 299 
AMH seems to be sustained for up to six months after LOD. Further subgroup analysis taking into 300 
account all possible confounding factors consistently showed a significant decline in postoperative 301 
serum AMH. The sub-analysis including studies with one- and three-month follow-up and studies 302 
using IOT AMH kit revealed low heterogeneity. This suggests that the high heterogeneity between 303 
studies seems to be due to variation in the follow-up periods and in the AMH assay kits used.  304 
The exact mechanism of the post-LOD fall in circulating AMH remains uncertain. A possible 305 
explanation could be a decrease in AMH synthesis due to loss of the primary, pre-antral and small 306 
antral follicles, which are the main source of AMH, as a result of thermal damage during LOD 307 
(Weenen et al. 2004, Anderson et al. 2010). This hypothesis is further supported by the preliminary 308 
finding of an obvious trend towards a decline in AFC after LOD, although this did not reach statistical 309 
significance, possibly due to the small numbers involved in that analysis and the high heterogeneity. 310 
Furthermore, we have recently reported a similar decline of circulating AMH following ovarian 311 
cystectomy (Raffi et al. 2012, Mohamed et al. 2016). This suggests that any surgical trauma to the 312 
ovary is associated with loss of ovarian follicles with subsequent reduction in AMH production. 313 
Whether this effect on AFC and AMH is temporary with subsequent recovery remains to be 314 
investigated with further long term studies. Interestingly, two studies, which are included in this meta-315 
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analysis, reported a significant postoperative decline of AFC, which was sustained for up to six 316 
months in one study (Seyam et al. 2014), but seemed to have recovered at six-month follow-up in the 317 
other study (Rezk et al. 2016).  These conflicting data may explain the outcome of the pooled 318 
analysis, which revealed no significant change in AFC at six-month follow-up.  Further adequately 319 
designed short, medium and long-term cohort studies are required to address this issue. 320 
It is interesting to see that even unilateral ovarian drilling caused a significant decline in circulating 321 
AMH, refuting the hypothesis that unilateral treatment could be less damaging to the ovarian reserve. 322 
It is worth mentioning that ovulation and pregnancy rates were higher in women undergoing bilateral 323 
versus unilateral ovarian drilling (Rezk et al. 2016). It is therefore possible to conclude that limiting 324 
the drilling to one ovary may compromise the success rates without any significant benefits to ovarian 325 
reserve. It was also interesting to see that despite the wide variation of the amount of energy used in 326 
different studies ranging between 450 and 1200 J per ovary, the decline in circulating AMH was more 327 
or less similar in all studies. This suggests that the range of energy doses utilised in these studies seem 328 
to be relatively safe to ovarian function with no excessive tissue damage with the higher doses.  329 
One of the two RCTs in this meta-analysis compared AMH changes after LOD vs. transvaginal hydro-330 
laparoscopic ovarian drilling (TH-LOD) (Giampaolino et al. 2016). In order to minimise heterogeneity 331 
between studies we decided to exclude the group undergoing TH-LOD due to the significant 332 
differences in techniques between this approach and the standard LOD used in all included studies. 333 
Whilst TH-LOD utilises bipolar diathermy, LOD on the other hand uses monopolar diathermy. 334 
Interestingly, there was no difference in the AMH changes after TH-LOD (Preoperative AMH, 335 
5.84±1.16 vs. postoperative, 4.83±1.10 ng/l, p<0.0001) compared to LOD (6.06±1.18 vs. 5.00±1.29 336 
ng/l, p<0.0001) (Giampaolino et al. 2016). This suggests that the degree of ovarian tissue damage is 337 
similar between the two energy modalities. This is surprising as bipolar diathermy is believed to 338 
reduce the risk of excessive ovarian tissue necrosis compared to monopolar energy.   339 
It is well-known that serum AMH levels are generally stable with minimal inter- and intra-cycle 340 
variations and with a very gradual decline (5.6% per year) with advancing age (Api 2009).  We 341 
therefore believe that a 43% decline in AMH level after LOD is a marked drop. However, it is still 342 
uncertain whether this reflects a real decline in ovarian reserve or merely reflects normalization of the 343 
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high preoperative serum AMH levels, which is a characteristic feature of PCOS (Amer et al. 2004). 344 
The well-established high pregnancy rates as well as the well-documented positive long-term 345 
reproductive effects of LOD favours the AMH normalisation hypothesis (Amer et al. 2002, Gjønnæss 346 
1998, Api 2009). This is further supported by the lack of any effect of LOD on circulating FSH. 347 
However, further long-term studies of ovarian reserve after LOD are required to support one of the 348 
above two hypotheses. Based on our findings and until further long-term data become available, 349 
clinicians could continue to offer LOD to their PCOS patients after carefully weighing the well-350 
known benefits against the potential risks to ovarian reserve.      351 
The main limitation of this review is the high heterogeneity between studies, possibly due to the 352 
variation in the AMH assay and amount of energy delivered to the ovary during LOD. Although, all 353 
studies used similar techniques of LOD, there were differences in the amount of energy delivered to 354 
the ovary with some studies applying 450 - 600J per ovary (Amer et al, 2009; Elmashad, 2011;  Rezk 355 
et al, 2016; Seyam et al, 2014) whilst others delivering up to 900 J (Seyam et al. 2014) and 1200 J 356 
(Giampaolino et al. 2016) per ovary.  357 
In conclusion, LOD significantly lowers circulating AMH, but this may not necessarily reflect a real 358 
damage to ovarian reserve. Given its proven efficacy and its long-term benefits, LOD should remain 359 
as an option in the management of anovulatory PCOS patients. 360 
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Figure legends 
 
Figure 1. PRISMA Flow Chart of the study selection process 
 
 
 
Figure 2. WMD in serum AMH concentrations after laparoscopic ovarian drilling: pooled results for 
all seven studies  
 
Abbreviations: AMH, anti-Müllerian hormone; CI, confidence interval; WMD, weighted mean 
difference. 
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Figure 2. WMD in serum AMH concentrations after laparoscopic ovarian drilling: pooled results for all seven 
studies  
Abbreviations: AMH, anti-Müllerian hormone; CI, confidence interval; WMD, weighted mean difference.  
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Table 1 Modified Newcastle Ottawa scale for risk of bias and quality assessment of the included studies 
 
Author Year 
Selection  
(***) 
Comparability  
(****) 
Outcome  
(**)  
Overall  
Amer et al. 2009 ** **** ** 8 
Elmashad  2011 * **** ** 7 
Farzadi et al. 2012 ** *** ** 7 
Seyam et al. 2014 ** **** ** 8 
Sunj et al. 2014a ** **** ** 8 
Giampaolino et al. 2016 ** *** ** 7 
Rezk et al. 2016 ** **** ** 8 
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 Table 2 Characteristics of the seven studies included in the meta-analysis 
Authors & year country Design n 
Age (years) 
mean±SD 
Laterality 
Energy per 
ovary (J) 
FU 
Months 
AMH  
assay 
Secondary 
Outcomes 
Amer et al. 2009 UK Prospective cohort 29 28.4±0.9 Bilateral  450 6 IOT FSH 
Elmashad 2011 Kuwait Prospective cohort 23 28.8±3.1 Bilateral  450 3 IOT FSH, OV, AFC 
 Farzadi et al. 2012 Iran Prospective cohort 30 28.4±2.3 Bilateral  *** 6 EIA AFC 
Seyam et al. 2014 Egypt Prospective cohort 40 31.6±4.5 Bilateral 480-900 6 IOT FSH, AFC 
Sunj et al. 2014a Croatia Prospective cohort 96 
29.3±3.3 
29.3±3.1 
Unilateral=49 
Bilateral=47 
600 
~627¶ 
6 Gen II FSH, AFC, OV 
Giampaolino et al. 2016 Italy RCT* 119 18-40** Bilateral 480-1200 6 DSL FSH 
Rezk et al. 2016 Egypt RCT 105 
29.7±1.5 
29.8±1.4 
Unilateral=52  
Bilateral=53 
600 
~627¶ 
6 IOT AFC, FSH 
* RCT Arm 1, laparoscopy included in the study; Arm 2, laparotomy excluded 
** age range of participants, SD not available  
*** 6-7 punctures per ovary, but no data provided on energy 
¶ energy delivered as  60 J per 1cm
3
 of ovarian volume, which is equivalent to 627 J per a 10cm3 ovary 
Abbreviation: RCT, randomised controlled trial; FU, follow up; J, Joules; OV, ovarian volume; IOT,   Immunotech AMH enzyme immunoassay;   EIA, enzyme 
immunoassay (ELAab & USCNLIFE);      DSL,  Diagnostic System Laboratories ELISA  AMH kit 
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Table 3 Pre- and Post-operative serum AMH concentrations in all analysed studies 
 
Reference n Laterality Serum AMH (ng/ml), mean±SD 
Preoperative Postoperative  
(1 month) 
Postoperative  
(3 month) 
Postoperative  
(6 month) 
Amer et al. 2009 29 Bilateral  7.19 ± 5.0 6.75 ± 5.70 5.33 ± 3.90 3.68 ± 2.50 
Elmashad 2011 23 Bilateral 7.40 ± 4.60 ─ 4.20 ± 2.50 ─ 
Farzadi et al. 2012 30 Bilateral 8.40 ± 4.70 7.50 ± 4.50 7.00 ± 4.50 7.70 ± 4.40 
Seyam et al. 2014 40 Bilateral 5.99 ± 2.30 3.40 ± 1.70 3.20 ± 1.70 3.10 ± 1.50 
Sunj et al. 2014a 49 Unilateral 6.67 ± 2.89 5.02 ± 2.05 ─ 5.70 ± 2.05 
 47 Bilateral 7.42 ± 2.78 4.98 ± 1.68 ─ 5.60 ± 1.70 
 96 Overall 7.03 ± 2.85 5.00 ± 1.80 ─ 5.60 ± 1.80 
Giampaolino et al. 2016 119 Bilateral 6.06 ± 1.18 ─ ─ 5.00 ± 1.29 
Rezk et al. 2016 52 Unilateral 8.60 ± 2.30 ─ 6.40 ± 1.20 6.50 ± 1.30 
 53 Bilateral 8.70 ± 2.40 ─ 5.20 ± 1.30 5.50 ± 1.10 
 105 Overall 8.60 ± 2.30 ─ 5.79 ± 1.30 5.90 ± 1.30 
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Table 4 Pre- and Post-operative serum FSH concentrations in all analysed studies.  
 
Reference n Laterality Serum FSH (IU/L), mean±S.D. 
Preoperative Postoperative  
(1 month) 
Postoperative  
(3 month) 
Postoperative  
(6 month) 
Amer et al. 2009 29 Bilateral 5.3 ± 1.4 4.9±1.6 ─ ─ 
Elmashad 2011 23 Bilateral  4.9 ± 1.6 ─ 4.1 ± 1.4 ─ 
Seyam et al. 2014 40 Bilateral 5.4 ± 2.7 5.7 ± 2.3 5.5 ± 2.1 5.45 ± 2.4 
Sunj et al. 2014a 49 Unilateral ─ ─ ─ ─ 
 47 Bilateral ─ ─ ─ ─ 
 96 Overall 5.2 ± 1.17 5.7 ± 1.2 ─ 6.1 ± 1.2 
Rezk et al. 2016 52 Unilateral 5.3 ± 1.4 ─ 5.41 ± 1.3 5.26 ± 1.4 
 53 Bilateral 5.5 ± 1.2 ─ 5.52 ± 1.3 5.49 ± 1.3 
 105 Overall 5.4 ± 1.3 ─ ─ 5.3 ± 1.3 
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Table 5 Pre- and Post-operative antral follicle count (AFC) in all analysed studies. 
 
Reference n Laterality AFC, mean±S.D. 
 
  Preoperative Postoperative  
(1 month) 
Postoperative  
(3 month) 
Postoperative  
(6 month) 
Elmashad 2011 23 Bilateral 29.0 ± 2.4 ─ 15.0 ± 2.2 ─ 
Seyam et al. 2014 40 Bilateral 16.75 ± 3.2 14.2 ± 2.8 12.5 ± 2.6 12.2 ± 1.6 
Sunj et al. 2014a 49 Unilateral ─ ─ ─ ─ 
 47 Bilateral ─  ─ ─ ─ 
 96 Overall 14.8 ± 2.7 14.8 ± 4.8 ─ 21.07 ± 8.2 
Rezk et al. 2016 52 Unilateral 19.1 ± 5.4 ─ 15.2 ± 3.3 18.6 ± 3.1 
 53 Bilateral 18.9 ± 5.5 ─ 15.1 ± 3.2 16.4 ± 3.2 
 105 Overall 18.9 ± 5.4 ─ 15.1 ± 3.1 17.4 ± 3.3 
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